Fr. 178.00

Leukemia Stem Cells in Hematologic Malignancies

English · Hardback

Shipping usually within 2 to 3 weeks (title will be printed to order)

Description

Read more

This book introduces readers to the biology of leukemia stem cells (LSCs) and emphasizes the necessity and importance of targeting LSCs in the treatment of hematopoietic malignancies. It addresses the role of leukemia stem cells in different leukemia diseases and molecular signatures, as well as the metabolic and epigenetic regulation of leukemia stem cell function. With regard to solid tumors, a significant number of blood cancers are believed to be derived from leukemia stem cells (LSCs), which are responsible for disease progression, relapse and drug resistance. Consequently, new therapeutic strategies need to be developed by focusing on the complete eradication of LSCs. Given its scope, the book offers a valuable asset for graduate students and scientists in the fields of cell biology and cancer research etc.

List of contents


Role of leukemia stem cells in pathogenesis of hematologic malignancies.- Leukemia stem cells in chronic myeloid leukemia.- Leukmeia stem cells in MLL-rearranged acute myeloid leukemia.- Interaction between leukmeia stem cells and bone marrow environment.- Molecular signatures of leukemia stem cells.- Metabolic regulation of leukemia stem cell function.- Epigenetic regulation of leukmeia stem cell function.- DNA instability and leukemia stem cell function.- Tumor suppressor genes in leukemia stem cells.- Targeting leukemia stem cells.- Leukemia stem cells and drug resistance.- Hypoxia and leukemia.

About the author

Dr. Haojian Zhang
Dr. Shaoguang Li

Summary

This book introduces readers to the biology of leukemia stem cells (LSCs) and emphasizes the necessity and importance of targeting LSCs in the treatment of hematopoietic malignancies. It addresses the role of leukemia stem cells in different leukemia diseases and molecular signatures, as well as the metabolic and epigenetic regulation of leukemia stem cell function. With regard to solid tumors, a significant number of blood cancers are believed to be derived from leukemia stem cells (LSCs), which are responsible for disease progression, relapse and drug resistance. Consequently, new therapeutic strategies need to be developed by focusing on the complete eradication of LSCs. Given its scope, the book offers a valuable asset for graduate students and scientists in the fields of cell biology and cancer research etc.

Product details

Assisted by LI (Editor), Li (Editor), Shaoguang Li (Editor), Haojia Zhang (Editor), Haojian Zhang (Editor)
Publisher Springer, Berlin
 
Languages English
Product format Hardback
Released 01.01.2019
 
EAN 9789811373411
ISBN 978-981-1373-41-1
No. of pages 229
Dimensions 160 mm x 240 mm x 20 mm
Weight 519 g
Illustrations VIII, 229 p. 40 illus., 37 illus. in color.
Series Advances in Experimental Medic
Advances in Experimental Medicine and Biology
Subjects Natural sciences, medicine, IT, technology > Medicine > Clinical medicine

B, Biomedical and Life Sciences, Cancer Research, Biomedical Research, Genetics (non-medical), Stem Cell Biology, stem cells

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.